Category Archives: (Sandbox Syndication Account) Health News (Master Feed)

(Reuters) - Sanofi on Friday mapped out a potential separate listing of its consumer healthcare business from the fourth quarter of next year, as it plans to shore up new drug development spending at ...

By Maggie Fick BARCELONA (Reuters) - Soaring demand for obesity drugs was in the spotlight at the world's largest trade show for the pharmaceutical services industry this week, as it fuels a boom for ...

By Maggie Fick and Jacob Gronholt-Pedersen LONDON/COPENHAGEN (Reuters) - When Novo Nordisk publishes third-quarter results next week investors and analysts are hoping the company will clarify when lim...

(Reuters) - French drugmaker Sanofi said on Friday it was looking into the separate listing of its Consumer Healthcare business from the fourth quarter of next year and that it plans to boost drug dev...

By David Gaffen and Manas Mishra (Reuters) - Healthcare companies who profit from treating obese and overweight patients are trying to convince investors that powerful new weight-loss drugs won't shri...

(Reuters) - Eli Lilly and Company said on Thursday that the U.S. health regulator had approved its drug for treating adults with moderately to severely active ulcerative colitis, a type of chronic inf...

(Reuters) - Bio-Rad Laboratories on Thursday lowered its annual revenue growth forecast, given the uncertain pace of the biopharma sector's recovery and ongoing macro challenges, sending the company's...

(Reuters) - Medical device maker Dexcom on Thursday raised its annual revenue forecast and beat quarterly estimates on strong demand for its continuous glucose monitoring (CGM) devices, sending its sh...

(Reuters) -Catalyst Pharmaceuticals said on Thursday that U.S. health regulators have approved its partner Santhera Pharmaceuticals' drug to treat Duchenne muscular dystrophy (DMD), a rare muscle-wast...

(Reuters) - Britain's medicines regulator on Thursday warned the public about buying fake weight-loss pens claiming to contain Novo Nordisk's diabetes drug Ozempic or weight-loss drug Saxenda after re...